Prudential Financial’s Calithera Biosciences, Inc CALA Stock Holding History

Prudential Financial’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-696	Closed	-$29K	–	2646
2021 Q2	$29K	Buy	696 +70	+11%	+$3.08K	﹤0.01%	2532
2021 Q1	$30K	Buy	+626	New	+$36.4K	﹤0.01%	2470
2020 Q2	–	Sell	-1,630	Closed	-$144K	–	2493
2020 Q1	$144K	Sell	1,630 -386	-19%	-$46K	﹤0.01%	2221
2019 Q4	$230K	Sell	2,016 -1,075	-35%	-$80.8K	﹤0.01%	2297
2019 Q3	$191K	Sell	3,091 -1,753	-36%	-$140K	﹤0.01%	2322
2019 Q2	$378K	Sell	4,844 -1,138	-19%	-$129K	﹤0.01%	2165
2019 Q1	$807K	Sell	5,982 -1,441	-19%	-$151K	﹤0.01%	1951
2018 Q4	$595K	Buy	7,423 +82	+1%	+$8.09K	﹤0.01%	1959
2018 Q3	$771K	Sell	7,341 -2,959	-29%	-$282K	﹤0.01%	1946
2018 Q2	$1.03M	Buy	+10,300	New	+$1.17M	﹤0.01%	1891

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial's CALA Position: Q3 2021 in Review

Prudential Financial sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 696 shares — an estimated $29K sold.

Prudential Financial first reported a position in CALA in Q2 2018 and held it in 10 quarters. The position peaked at $1.03M in Q2 2018. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

Prudential Financial reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
Prudential Financial sold 696 Calithera Biosciences, Inc shares in Q3 2021, an estimated $29K.
Prudential Financial first reported a position in Calithera Biosciences, Inc in Q2 2018 and held it in 10 quarters.
Prudential Financial's Calithera Biosciences, Inc position peaked at $1.03M in Q2 2018.
66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Prudential Financial's 13F filing for Q3 2021, filed 15 Nov 2021.